GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling

Molecular Neurobiology

Volumn 56, Issue 2, 2019, Pages 1517-1530

  Matias, Diana ^a,b   Dubois, Luiz Gustavo ^a,b   Pontes, Bruno ^b   Rosário, Luciane ^a,b   Ferrer, Valeria Pereira ^a   Balça Silva, Joana ^a,c,d   Fonseca, Anna Carolina Carvalho ^b   Macharia, Lucy Wanjiku ^a,b   Romão, Luciana ^b   e Spohr, Tania Cristina Leite de Sampaio ^a   Chimelli, Leila ^a   Filho, Paulo Niemeyer ^a   Lopes, Maria Celeste ^c,e   Abreu, José Garcia ^b   Lima, Flavia Regina Souza ^b   Moura Neto, Vivaldo ^a  

^a Instituto Estadual do Cérebro Paulo Niemeyer   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Glioblastoma; M2 like phenotype; Microglia; Wnt catenin pathway; Wnt3a

Indexed keywords

ARGINASE 1; BETA CATENIN; CELL PROTEIN; CYCLIN D1; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MYC PROTEIN; NANOTUBE; STRESS INDUCIBLE PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; CTNNB1 PROTEIN, HUMAN; WNT3A PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IL 10 GENE; IL1BETA GENE; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MICROGLIA; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; CELL MOTION; GENETICS; METABOLISM; PHYSIOLOGY; WNT SIGNALING;

BETA CATENIN; CELL MOVEMENT; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; MICROGLIA; PHENOTYPE; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 85048536217     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-018-1150-5     Document Type: Article

References (45)

1. Stupp R, Hegi ME, Gilbert MR, Chakravarti A (2007) Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25:4127–4136. 10.1200/JCO.2007.11.8554
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. 10.1007/s00401-007-0243-4
3. Friedmann-Morvinski D (2014) Glioblastoma heterogeneity and cancer cell plasticity. Crit Rev Oncog 19:327–336
4. Albini A, Bruno A, Gallo C, Pajardi G, Noonan DM, Dallaglio K (2015) Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity. Connect Tissue Res 56:414–425. 10.3109/03008207.2015.1066780
5. Balça-Silva J, Matias D, Do Carmo A, Dubois LG, Gonçalves AC, Girão H, Silva Canedo NH, Correia AH et al (2017) Glioblastoma entities express subtle differences in molecular composition and response to treatment. Oncol Rep 38:1341–1352. 10.3892/or.2017.5799
6. Abou-Antoun TJ, Hale JS, Lathia JD, Dombrowski SM (2017) Brain cancer stem cells in adults and children: cell biology and therapeutic implications. Neurotherapeutics 14:372–384. 10.1007/s13311-017-0524-0
7. Roos A, Ding Z, Loftus JC, Tran NL (2017) Molecular and microenvironmental determinants of glioma stem-like cell survival and invasion. Front Oncol 7:120. 10.3389/fonc.2017.00120
8. Garcia C, Dubois LG, Xavier AL, Geraldo LH, da Fonseca ACC, Correia AH, Meirelles F, Ventura G et al (2014) The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. BMC Cancer 14:923. 10.1186/1471-2407-14-923
9. Carvalho da Fonseca AC, Wang H, Fan H, Chen X, Zhang I, Zhang L, Lima FRS, Badie B (2014) Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages. J Neuroimmunol 274:71–77. 10.1016/j.jneuroim.2014.06.021
10. Olah M, Raj D, Brouwer N, de Haas AH, Eggen BJL, den Dunnen WFA, Biber KPH, Boddeke HWGM (2012) An optimized protocol for the acute isolation of human microglia from autopsy brain samples. Glia 60:96–111. 10.1002/glia.21251
11. Razavi S-M, Lee KE, Jin BE, Aujla PS, Gholamin S, Li G (2016) Immune evasion strategies of glioblastoma. Front Surg 3:11. 10.3389/fsurg.2016.00011
12. da Fonseca ACC, Amaral R, Garcia C et al (2016) Microglia in cancer: for good or for bad? Adv Exp Med Biol 949:245–261. 10.1007/978-3-319-40764-7_12
13. Audia A, Conroy S, Glass R, Bhat KPL (2017) The impact of the tumor microenvironment on the properties of glioma stem-like cells. Front Oncol 7:143. 10.3389/fonc.2017.00143
14. Van Meir E, Sawamura Y, Diserens AC et al (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50:6683–6688
15. Woiciechowsky C, Asadullah K, Nestler D, Glockner F, Robinson PN, Volk HD, Vogel S, Lanksch WR (1997) Different release of cytokines into the cerebrospinal fluid following surgery for intra- and extra-axial brain tumours. Acta Neurochir 139:619–624
16. Constam DB, Philipp J, Malipiero UV et al (1992) Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404–1410
17. Hambardzumyan D, Gutmann DH, Kettenmann H (2016) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19:20–27. 10.1038/nn.4185
18. Markovic DS, Glass R, Synowitz M, Rooijen N, Kettenmann H (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64:754–762
19. Matias D, Predes D, Niemeyer Filho P, Lopes MC, Abreu JG, Lima FRS, Moura Neto V (2017) Microglia-glioblastoma interactions: new role for Wnt signaling. Biochim Biophys Acta 1868:333–340. 10.1016/j.bbcan.2017.05.007
20. Zhang I, Alizadeh D, Liang J, Zhang L, Gao H, Song Y, Ren H, Ouyang M et al (2016) Characterization of arginase expression in glioma-associated microglia and macrophages. PLoS One 11:e0165118. 10.1371/journal.pone.0165118
21. Fonseca ACC, da Romão L, Amaral RF et al (2012) Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience 200:130–141. 10.1016/j.neuroscience.2011.10.025
22. Denysenko T, Annovazzi L, Cassoni P et al (2016) WNT/β-catenin signaling pathway and downstream modulators in low- and high-grade glioma. Cancer Genomics Proteomics 13:31–45
23. Halleskog C, Mulder J, Dahlström J, Mackie K, Hortobágyi T, Tanila H, Kumar Puli L, Färber K et al (2011) WNT signaling in activated microglia is proinflammatory. Glia 59:119–131. 10.1002/glia.21081
24. Zheng H, Jia L, Liu C-C, Rong Z, Zhong L, Yang L, Chen XF, Fryer JD et al (2017) TREM2 promotes microglial survival by activating Wnt/β-catenin pathway. J Neurosci 37:1772–1784. 10.1523/JNEUROSCI.2459-16.2017
25. Dijksterhuis JP, Arthofer E, Marinescu VD, Nelander S, Uhlén M, Pontén F, Mulder J, Schulte G (2015) High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes. Exp Cell Res 339:280–288. 10.1016/j.yexcr.2015.10.022
26. Faria J, Romão L, Martins S, Alves T, Mendes FA, de Faria GP, Hollanda R, Takiya C et al (2006) Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 74:562–572. 10.1111/j.1432-0436.2006.00090.x
27. Kahn SA, Biasoli D, Garcia C et al (2012) Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. Curr Top Med Chem 12:2082–2093
28. Lima FR, Gervais A, Colin C et al (2001) Regulation of microglial development: a novel role for thyroid hormone. J Neurosci 21:2028–2038
29. Towbin H, Staehelin T, Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979 Biotechnology 24:145–149
30. Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG (2011) Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci 89:545–554. 10.1016/j.lfs.2011.05.003
31. Oloumi A, Syam S, Dedhar S (2006) Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 25:7747–7757. 10.1038/sj.onc.1209752
32. Liao DJ, Thakur A, Wu J, Biliran H, Sarkar FH (2007) Perspectives on c-Myc, cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit Rev Oncog 13:93–158
33. Clément-Lacroix P, Ai M, Morvan F et al (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A 102:17406–17411. 10.1073/pnas.0505259102
34. Ajmone-Cat MA, D’Urso MC, di Blasio G, Brignone MS, de Simone R, Minghetti L (2016) Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells. Brain Behav Immun 55:225–235. 10.1016/j.bbi.2015.11.012
35. Crain JM, Nikodemova M, Watters JJ (2013) Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 91:1143–1151. 10.1002/jnr.23242
36. Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C et al (2013) Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer 13:537. 10.1186/1471-2407-13-537
37. Yamaguchi H, Condeelis J (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773:642–652. 10.1016/j.bbamcr.2006.07.001
38. Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S (1998) Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 3:659–670
39. Holmes KC (2009) Structural biology: actin in a twist. Nature 457:389–390. 10.1038/457389a
40. Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh ML, Shiras A (2013) Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci 54:44–57. 10.1016/j.mcn.2013.01.001
41. Zhang Z-M, Yang Z, Zhang Z (2015) Distribution and characterization of tumor-associated macrophages/microglia in rat C6 glioma. Oncol Lett 10:2442–2446. 10.3892/ol.2015.3533
42. O’Connor T, Borsig L, Heikenwalder M (2015) CCL2-CCR2 signaling in disease pathogenesis. Endocr Metab Immune Disord Drug Targets 15:105–118
43. Pontes B, Viana NB, Campanati L, Farina M, Neto VM, Nussenzveig HM (2008) Structure and elastic properties of tunneling nanotubes. Eur Biophys J 37:121–129. 10.1007/s00249-007-0184-9
44. Hooper C, Sainz-Fuertes R, Lynham S, Hye A, Killick R, Warley A, Bolondi C, Pocock J et al (2012) Wnt3a induces exosome secretion from primary cultured rat microglia. BMC Neurosci 13:144. 10.1186/1471-2202-13-144
45. Nawaz M, Fatima F (2017) Extracellular vesicles, tunneling nanotubes, and cellular interplay: synergies and missing links. Front Mol Biosci 4:50. 10.3389/fmolb.2017.00050